REN and type 2 diabetes mellitus: Studies have shown that reducing hyperfiltration through drugs that target the renin–angiotensin–aldosterone system (RAAS) or weight loss can exert protective effects on the kidneys in patients with type 2 diabetes mellitus (T2DM), slowing down the decline in GFR over time, similar to the rate observed in healthy aging adults [21,22].